StonvexLoading…
StonvexCore line items from GM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $48.26B | $39.35B | $167.97B | $126.99B | $82.73B |
Operating Income | Not available | $2.93B | $2.91B | $6.55B | $5.48B |
Net Income | Not available | $2.63B | $2.70B | $6.01B | $4.68B |
EPS (Diluted) | $3.28 | $2.82 | $3.27 | $6.64 | $5.28 |
Total Assets | Not available | $280.97B | $281.28B | $288.17B | $289.38B |
Total Liabilities | Not available | $216.28B | $218.12B | $219.77B | $220.93B |
Cash & Equivalents | Not available | $19.80B | $20.95B | $22.91B | $22.38B |
Free Cash Flow OCF − CapEx | Not available | $1.44B | $17.56B | $13.99B | $9.02B |
Shares Outstanding | Not available | 902.00M | 904.00M | 933.00M | 957.00M |